Soluble CD40L in Stem Cell Products
-
Published:2013-02-27
Issue:
Volume:
Page:241-245
-
ISSN:2215-0994
-
Container-title:Stem Cells and Cancer Stem Cells, Volume 12
-
language:
-
Short-container-title:
Publisher
Springer Netherlands
Reference19 articles.
1. Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR (2002a) Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106:896–899
2. Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD (2002b) CD40L Stabilizes arterial thrombi by a beta3 integrin–dependent mechanism. Nat Med 8:247–252
3. Aye MT, Palmer DS, Giulivi A, Hashemi S (1995) Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 35:117–124
4. Blumberg N, Gettings KF, Turner C, Heal JM, Phipps RP (2006) An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion 46:1813–1821
5. Chew M, Rahman M, Ihrman L, Erson A, Zhang S, Thorlacius H (2010) Soluble CD40L (CD154) is increased in patients with shock. Inflamm Res 59:979–982